Surge in Lawsuits as Patients Suffering from Defective Hernia Mesh Seek Justice Across All States

Across the United U.S., thousands of lawsuits are progressing through various courts where plaintiffs claim they suffered severe complications from defective hernia mesh implants used during surgeries. The legal battles involve several major medical device manufacturers, including Ethicon, a subsidiary of Johnson & Johnson, which has already reached settlement in most of its cases. Other prominent defendants include C.R. Bard, now part of Beckton Dickinson, Covidien, and Atrium Medical Corp. At the heart of these lawsuits are allegations that the hernia meshes, which are intended to support weakened or damaged tissue, were defectively designed or … Read more

Patients Alleging Severe Health Issues From Ozempic Prompt Wave of Lawsuits, Seek Justice and Compensation

Philadelphia, PA — Legal teams are currently examining potential lawsuits against the makers of Ozempic, focusing on claims that the diabetes and weight loss drug has led to severe gastrointestinal issues, including gastroparesis. This condition, characterized primarily by delayed stomach emptying, can cause chronic and disabling symptoms like nausea and abdominal pain, materially impacting quality of life. Ozempic, known generically as semaglutide, is prescribed widely in the management of type 2 diabetes and as a weight loss aid. It functions by mimicking a hormone that signals the pancreas to release insulin, subsequently lowering blood sugar. … Read more

Pharmacy Benefit Managers and Drug Companies Face Lawsuit for Inflating Insulin Prices, Targeting Vulnerable Patients in Indiana

Indianapolis, Indiana – The Attorney General of Indiana, Todd Rokita, has filed a lawsuit alleging that pharmacy benefit managers (PBMs) and drug companies have colluded to maintain high insulin prices. Rokita claims that these companies are exploiting vulnerable individuals in need of this vital medication. The lawsuit does not specifically name the drug company Eli Lilly, even though it settled a class-action lawsuit last year over allegations of insulin price fixing for over $13 million. Among the companies named in the lawsuit are Caremark PCS and CVS Healthcorp, both associated with CVS, one of the … Read more

Patients Seek Compensation in Ozempic Lawsuit Claims Against Novo Nordisk

Patients who have experienced severe side effects from the diabetes drug Ozempic are filing lawsuits against Novo Nordisk, claiming that the pharmaceutical company failed to warn them about the potential risks. While Ozempic is only approved by the FDA for treating type 2 diabetes, it has been used off-label for weight loss due to its effectiveness in reducing appetite and producing a feeling of fullness. However, the drug has been associated with various side effects, including gastroparesis (stomach paralysis), thyroid tumors or cancer, hypoglycemia, pancreatitis, and gallstones. The exact worth of each Ozempic claim is … Read more